Mark Adler Joins Medtronic Diabetes as Director, Research and Development, Sensors Engineering

Life Science Partner recruits former Vice President of Manufacturing and Manufacturing Engineering at GluMetrics

Life Science Partner announces the recruitment of Mark Adler to become Director, Research and Development, Sensors Engineering for Medtronic Diabetes.  Medtronic Diabetes is the world leader in insulin pump therapy and continuous glucose monitoring.

In his most recent role at GluMetrics, Adler was responsible for building the intensive care unit glucose sensor product portfolio for the emerging medical device company.  He has a broad background in breakthrough device development in many different platforms – including coating vascular stents at Devax and creating a new sensor platform at DexCom as Senior Director of Manufacturing Operations and Engineering.  This new role is somewhat of a homecoming, as he was previously the Director of Advanced Engineering at Medtronic AVE.

In his new role at Medtronic Diabetes, Adler will be responsible for determining and executing the overall strategic technology plan for the sensors development organization, as they help build the next-generation sensors and cutting edge continuous glucose monitoring solutions.

“Adler is a passionate, highly motivated engineering executive with an impressive background in sensor development for the diabetes market” noted Tom Callaway, MD, founder and president of Life Science Partner.  “He has broad management experience across all functions of a medical device organization and will bring leadership and quality execution to Medtronic Diabetes’ portfolio of continuous glucose monitoring solutions.”

Adler received his Bachelor of Technology Degree in Mechanical Engineering from the Rochester Institute of Technology and his Masters in Business Administration from Argosy University, Seattle.